The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Medical News

Gilead Adds Discount, Price Freeze for AIDS Drugs

June 14, 2010

Gilead Sciences recently announced an extension of discounts and price freezes for several HIV drugs used by clients of AIDS drug assistance programs. Many state ADAPs continue to face budget shortfalls, and as of May there were 1,143 individuals on waiting lists for ADAP assistance, the drug maker noted in a statement issued jointly with the ADAP Crisis Task Force. Discounts and price freezes cover Truvada (emtricitabine and tenofovir), Viread (tenofovir), and Emtriva (emtricitabine) through December 31, 2013. In addition, Gilead said it is expanding its patient assistance program and eliminating minimum payments for patients in its co-pay assistance program. The ADAP Crisis Task Force was formed in 2002 by several state AIDS directors to respond to fiscal emergencies affecting ADAPs.

Back to other news for June 2010

Adapted from:
Silicon Valley Business Journal

  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
See Also
More News and Analysis on HIV Drug Pricing

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining: